1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gaucher Disease Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gaucher Disease by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gaucher Disease by Country/Region, 2017, 2022 & 2028

2.2 Gaucher Disease Segment by Type

2.2.1 Enzyme Replacement Therapy

2.2.2 Substrate Reduction Therapy

2.3 Gaucher Disease Sales by Type

2.3.1 Global Gaucher Disease Sales Market Share by Type (2017-2022)

2.3.2 Global Gaucher Disease Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gaucher Disease Sale Price by Type (2017-2022)

2.4 Gaucher Disease Segment by Application

2.4.1 Non-neuronopathic Gaucher Disease

2.4.2 Neuronopathic Gaucher Disease

2.5 Gaucher Disease Sales by Application

2.5.1 Global Gaucher Disease Sale Market Share by Application (2017-2022)

2.5.2 Global Gaucher Disease Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gaucher Disease Sale Price by Application (2017-2022)

3 Global Gaucher Disease by Company

3.1 Global Gaucher Disease Breakdown Data by Company

3.1.1 Global Gaucher Disease Annual Sales by Company (2020-2022)

3.1.2 Global Gaucher Disease Sales Market Share by Company (2020-2022)

3.2 Global Gaucher Disease Annual Revenue by Company (2020-2022)

3.2.1 Global Gaucher Disease Revenue by Company (2020-2022)

3.2.2 Global Gaucher Disease Revenue Market Share by Company (2020-2022)

3.3 Global Gaucher Disease Sale Price by Company

3.4 Key Manufacturers Gaucher Disease Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gaucher Disease Product Location Distribution

3.4.2 Players Gaucher Disease Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gaucher Disease by Geographic Region

4.1 World Historic Gaucher Disease Market Size by Geographic Region (2017-2022)

4.1.1 Global Gaucher Disease Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gaucher Disease Annual Revenue by Geographic Region

4.2 World Historic Gaucher Disease Market Size by Country/Region (2017-2022)

4.2.1 Global Gaucher Disease Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gaucher Disease Annual Revenue by Country/Region

4.3 Americas Gaucher Disease Sales Growth

4.4 APAC Gaucher Disease Sales Growth

4.5 Europe Gaucher Disease Sales Growth

4.6 Middle East & Africa Gaucher Disease Sales Growth

5 Americas

5.1 Americas Gaucher Disease Sales by Country

5.1.1 Americas Gaucher Disease Sales by Country (2017-2022)

5.1.2 Americas Gaucher Disease Revenue by Country (2017-2022)

5.2 Americas Gaucher Disease Sales by Type

5.3 Americas Gaucher Disease Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gaucher Disease Sales by Region

6.1.1 APAC Gaucher Disease Sales by Region (2017-2022)

6.1.2 APAC Gaucher Disease Revenue by Region (2017-2022)

6.2 APAC Gaucher Disease Sales by Type

6.3 APAC Gaucher Disease Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gaucher Disease by Country

7.1.1 Europe Gaucher Disease Sales by Country (2017-2022)

7.1.2 Europe Gaucher Disease Revenue by Country (2017-2022)

7.2 Europe Gaucher Disease Sales by Type

7.3 Europe Gaucher Disease Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gaucher Disease by Country

8.1.1 Middle East & Africa Gaucher Disease Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gaucher Disease Revenue by Country (2017-2022)

8.2 Middle East & Africa Gaucher Disease Sales by Type

8.3 Middle East & Africa Gaucher Disease Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gaucher Disease

10.3 Manufacturing Process Analysis of Gaucher Disease

10.4 Industry Chain Structure of Gaucher Disease

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gaucher Disease Distributors

11.3 Gaucher Disease Customer

12 World Forecast Review for Gaucher Disease by Geographic Region

12.1 Global Gaucher Disease Market Size Forecast by Region

12.1.1 Global Gaucher Disease Forecast by Region (2023-2028)

12.1.2 Global Gaucher Disease Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gaucher Disease Forecast by Type

12.7 Global Gaucher Disease Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Gaucher Disease Product Offered

13.1.3 Sanofi Gaucher Disease Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Takeda

13.2.1 Takeda Company Information

13.2.2 Takeda Gaucher Disease Product Offered

13.2.3 Takeda Gaucher Disease Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Takeda Main Business Overview

13.2.5 Takeda Latest Developments

13.3 Actelion Pharma

13.3.1 Actelion Pharma Company Information

13.3.2 Actelion Pharma Gaucher Disease Product Offered

13.3.3 Actelion Pharma Gaucher Disease Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Actelion Pharma Main Business Overview

13.3.5 Actelion Pharma Latest Developments

13.4 Pfizer (Protalix)

13.4.1 Pfizer (Protalix) Company Information

13.4.2 Pfizer (Protalix) Gaucher Disease Product Offered

13.4.3 Pfizer (Protalix) Gaucher Disease Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer (Protalix) Main Business Overview

13.4.5 Pfizer (Protalix) Latest Developments

13.5 ISU ABXIS

13.5.1 ISU ABXIS Company Information

13.5.2 ISU ABXIS Gaucher Disease Product Offered

13.5.3 ISU ABXIS Gaucher Disease Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 ISU ABXIS Main Business Overview

13.5.5 ISU ABXIS Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Gaucher Disease Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gaucher Disease Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Enzyme Replacement Therapy

Table 4. Major Players of Substrate Reduction Therapy

Table 5. Global Gaucher Disease Sales by Type (2017-2022) & (K Units)

Table 6. Global Gaucher Disease Sales Market Share by Type (2017-2022)

Table 7. Global Gaucher Disease Revenue by Type (2017-2022) & ($ million)

Table 8. Global Gaucher Disease Revenue Market Share by Type (2017-2022)

Table 9. Global Gaucher Disease Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Gaucher Disease Sales by Application (2017-2022) & (K Units)

Table 11. Global Gaucher Disease Sales Market Share by Application (2017-2022)

Table 12. Global Gaucher Disease Revenue by Application (2017-2022)

Table 13. Global Gaucher Disease Revenue Market Share by Application (2017-2022)

Table 14. Global Gaucher Disease Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Gaucher Disease Sales by Company (2020-2022) & (K Units)

Table 16. Global Gaucher Disease Sales Market Share by Company (2020-2022)

Table 17. Global Gaucher Disease Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Gaucher Disease Revenue Market Share by Company (2020-2022)

Table 19. Global Gaucher Disease Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Gaucher Disease Producing Area Distribution and Sales Area

Table 21. Players Gaucher Disease Products Offered

Table 22. Gaucher Disease Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Gaucher Disease Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Gaucher Disease Sales Market Share Geographic Region (2017-2022)

Table 27. Global Gaucher Disease Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Gaucher Disease Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Gaucher Disease Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Gaucher Disease Sales Market Share by Country/Region (2017-2022)

Table 31. Global Gaucher Disease Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Gaucher Disease Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Gaucher Disease Sales by Country (2017-2022) & (K Units)

Table 34. Americas Gaucher Disease Sales Market Share by Country (2017-2022)

Table 35. Americas Gaucher Disease Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Gaucher Disease Revenue Market Share by Country (2017-2022)

Table 37. Americas Gaucher Disease Sales by Type (2017-2022) & (K Units)

Table 38. Americas Gaucher Disease Sales Market Share by Type (2017-2022)

Table 39. Americas Gaucher Disease Sales by Application (2017-2022) & (K Units)

Table 40. Americas Gaucher Disease Sales Market Share by Application (2017-2022)

Table 41. APAC Gaucher Disease Sales by Region (2017-2022) & (K Units)

Table 42. APAC Gaucher Disease Sales Market Share by Region (2017-2022)

Table 43. APAC Gaucher Disease Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Gaucher Disease Revenue Market Share by Region (2017-2022)

Table 45. APAC Gaucher Disease Sales by Type (2017-2022) & (K Units)

Table 46. APAC Gaucher Disease Sales Market Share by Type (2017-2022)

Table 47. APAC Gaucher Disease Sales by Application (2017-2022) & (K Units)

Table 48. APAC Gaucher Disease Sales Market Share by Application (2017-2022)

Table 49. Europe Gaucher Disease Sales by Country (2017-2022) & (K Units)

Table 50. Europe Gaucher Disease Sales Market Share by Country (2017-2022)

Table 51. Europe Gaucher Disease Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Gaucher Disease Revenue Market Share by Country (2017-2022)

Table 53. Europe Gaucher Disease Sales by Type (2017-2022) & (K Units)

Table 54. Europe Gaucher Disease Sales Market Share by Type (2017-2022)

Table 55. Europe Gaucher Disease Sales by Application (2017-2022) & (K Units)

Table 56. Europe Gaucher Disease Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Gaucher Disease Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Gaucher Disease Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Gaucher Disease Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Gaucher Disease Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Gaucher Disease Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Gaucher Disease Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Gaucher Disease Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Gaucher Disease Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Gaucher Disease

Table 66. Key Market Challenges & Risks of Gaucher Disease

Table 67. Key Industry Trends of Gaucher Disease

Table 68. Gaucher Disease Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Gaucher Disease Distributors List

Table 71. Gaucher Disease Customer List

Table 72. Global Gaucher Disease Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Gaucher Disease Sales Market Forecast by Region

Table 74. Global Gaucher Disease Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Gaucher Disease Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Gaucher Disease Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Gaucher Disease Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Gaucher Disease Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Gaucher Disease Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Gaucher Disease Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Gaucher Disease Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Gaucher Disease Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Gaucher Disease Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Gaucher Disease Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Gaucher Disease Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Gaucher Disease Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Gaucher Disease Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Gaucher Disease Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Gaucher Disease Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Gaucher Disease Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Gaucher Disease Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Gaucher Disease Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Gaucher Disease Product Offered

Table 94. Sanofi Gaucher Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. Takeda Basic Information, Gaucher Disease Manufacturing Base, Sales Area and Its Competitors

Table 98. Takeda Gaucher Disease Product Offered

Table 99. Takeda Gaucher Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Takeda Main Business

Table 101. Takeda Latest Developments

Table 102. Actelion Pharma Basic Information, Gaucher Disease Manufacturing Base, Sales Area and Its Competitors

Table 103. Actelion Pharma Gaucher Disease Product Offered

Table 104. Actelion Pharma Gaucher Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Actelion Pharma Main Business

Table 106. Actelion Pharma Latest Developments

Table 107. Pfizer (Protalix) Basic Information, Gaucher Disease Manufacturing Base, Sales Area and Its Competitors

Table 108. Pfizer (Protalix) Gaucher Disease Product Offered

Table 109. Pfizer (Protalix) Gaucher Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Pfizer (Protalix) Main Business

Table 111. Pfizer (Protalix) Latest Developments

Table 112. ISU ABXIS Basic Information, Gaucher Disease Manufacturing Base, Sales Area and Its Competitors

Table 113. ISU ABXIS Gaucher Disease Product Offered

Table 114. ISU ABXIS Gaucher Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. ISU ABXIS Main Business

Table 116. ISU ABXIS Latest Developments

List of Figures

Figure 1. Picture of Gaucher Disease

Figure 2. Gaucher Disease Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gaucher Disease Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Gaucher Disease Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gaucher Disease Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Enzyme Replacement Therapy

Figure 10. Product Picture of Substrate Reduction Therapy

Figure 11. Global Gaucher Disease Sales Market Share by Type in 2021

Figure 12. Global Gaucher Disease Revenue Market Share by Type (2017-2022)

Figure 13. Gaucher Disease Consumed in Non-neuronopathic Gaucher Disease

Figure 14. Global Gaucher Disease Market: Non-neuronopathic Gaucher Disease (2017-2022) & (K Units)

Figure 15. Gaucher Disease Consumed in Neuronopathic Gaucher Disease

Figure 16. Global Gaucher Disease Market: Neuronopathic Gaucher Disease (2017-2022) & (K Units)

Figure 17. Global Gaucher Disease Sales Market Share by Application (2017-2022)

Figure 18. Global Gaucher Disease Revenue Market Share by Application in 2021

Figure 19. Gaucher Disease Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Gaucher Disease Revenue Market Share by Company in 2021

Figure 21. Global Gaucher Disease Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Gaucher Disease Revenue Market Share by Geographic Region in 2021

Figure 23. Global Gaucher Disease Sales Market Share by Region (2017-2022)

Figure 24. Global Gaucher Disease Revenue Market Share by Country/Region in 2021

Figure 25. Americas Gaucher Disease Sales 2017-2022 (K Units)

Figure 26. Americas Gaucher Disease Revenue 2017-2022 ($ Millions)

Figure 27. APAC Gaucher Disease Sales 2017-2022 (K Units)

Figure 28. APAC Gaucher Disease Revenue 2017-2022 ($ Millions)

Figure 29. Europe Gaucher Disease Sales 2017-2022 (K Units)

Figure 30. Europe Gaucher Disease Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Gaucher Disease Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Gaucher Disease Revenue 2017-2022 ($ Millions)

Figure 33. Americas Gaucher Disease Sales Market Share by Country in 2021

Figure 34. Americas Gaucher Disease Revenue Market Share by Country in 2021

Figure 35. United States Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Gaucher Disease Sales Market Share by Region in 2021

Figure 40. APAC Gaucher Disease Revenue Market Share by Regions in 2021

Figure 41. China Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Gaucher Disease Sales Market Share by Country in 2021

Figure 48. Europe Gaucher Disease Revenue Market Share by Country in 2021

Figure 49. Germany Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Gaucher Disease Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Gaucher Disease Revenue Market Share by Country in 2021

Figure 56. Egypt Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Gaucher Disease Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Gaucher Disease in 2021

Figure 62. Manufacturing Process Analysis of Gaucher Disease

Figure 63. Industry Chain Structure of Gaucher Disease

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles